ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,317Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 393

$406K Total Retail Price of All Prescriptions

Rank: 100 out of 393

740 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 740 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 740 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 10,385 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LEVOTHYROXINE SODIUM 652 604 1 3
SIMVASTATIN 631 578 2 1
OMEPRAZOLE 577 518 3 6
LISINOPRIL 520 479 4 2
HYDROCODONE-ACETAMINOPHEN 489 422 S3 5 5
METFORMIN HCL 379 353 6 7
ATENOLOL 377 375 7 13
ALENDRONATE SODIUM 362 347 8 16
AMLODIPINE BESYLATE 360 346 9 4
ALLOPURINOL 266 251 10 26
GLIMEPIRIDE 242 229 11 39
HYDROCHLOROTHIAZIDE 224 208 12 10
GABAPENTIN 212 197 13 15
METOPROLOL TARTRATE 212 199 13 9
ZOLPIDEM TARTRATE 208 179 15 11
WARFARIN SODIUM 160 153 16 17
FUROSEMIDE 149 132 17 8
SERTRALINE HCL 147 147 18 28
LOSARTAN POTASSIUM 137 130 19 12
VENTOLIN HFA 137 129 19 42
LOVASTATIN 127 127 21 14
IBUPROFEN 125 97 22 55
PRAVASTATIN SODIUM 122 109 23 18
TERAZOSIN HCL 119 119 24 38
POTASSIUM CHLORIDE 110 94 25 20
FLUTICASONE PROPIONATE 100 87 26 27
METOPROLOL SUCCINATE 99 87 27 22
CLONIDINE HCL 90 86 28 50
NAPROXEN 90 69 28 85
PLAVIX 90 88 28 51
CLOPIDOGREL 87 76 31 33
LANTUS SOLOSTAR 74 61 32 74
TRIAMCINOLONE ACETONIDE 71 68 33 94
KLOR-CON 10 68 67 34 113
RANITIDINE HCL 67 59 35 29
PROPRANOLOL HCL 66 66 36 134
DONEPEZIL HCL 65 65 37 34
DILTIAZEM 24HR ER 62 62 38 129
TAMSULOSIN HCL 61 61 39 25
ATORVASTATIN CALCIUM 61 58 39 19
CLOTRIMAZOLE-BETAMETHASONE 60 56 41 156
EVISTA 58 53 42 98
GEMFIBROZIL 53 51 43 62
ISOSORBIDE MONONITRATE ER 53 53 43 67
PAROXETINE HCL 51 40 45 61
CIPROFLOXACIN HCL 51 50 45 57
BACLOFEN 50 47 47 79
FLUOXETINE HCL 50 46 47 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 22, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.